OA
Orbimed Advisors LLC disclosed a 12.3% stake in ASPE
Orbimed Advisors LLC reported owning 12.3% of Aspen Neuroscience, Inc. (ASPE) (3,589,132 shares) in a Schedule 13D filed Nov 6, 2026.
A 13D means the holder may push for changes at the company.
- Disclosed
- Nov 6, 2026
- Source
- Schedule 13D